(Q43846809)

27 November 2017

title

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma (English)

1 reference

ORCID Public Data File 2021

27 November 2017

1 reference

author name string

Stephen L Chan

1

1 reference

27 November 2017

Frankie K F Mo

2

1 reference

27 November 2017

Cesar S C Wong

3

1 reference

27 November 2017

Charles M L Chan

4

1 reference

27 November 2017

Linda K S Leung

5

1 reference

27 November 2017

Edwin P Hui

6

1 reference

27 November 2017

Brigette B Ma

7

1 reference

27 November 2017

Anthony T C Chan

8

1 reference

27 November 2017

Tony S K Mok

9

1 reference

27 November 2017

Winnie Yeo

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

16 December 2011

1 reference

27 November 2017

1 reference

27 November 2017

volume

118

1 reference

27 November 2017

issue

16

1 reference

27 November 2017

page(s)

3984-3992

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

The impact of new data in the treatment of advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Frequencies of interferon-γ and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Interleukin-10 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Biological properties of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

7 January 2021

Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgica

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

7 January 2021

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

7 January 2021

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26726

7 January 2021

Identifiers

DOI

10.1002/CNCR.26726

1 reference

27 November 2017

1 reference